Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM4 | O15151 | 3/20 | 0.49 |
| ▸ | TP53 | P04637 | 3/20 | 0.49 |
| ▸ | MDM2 | Q00987 | 6/20 | 0.46 |
| ▸ | SLC17A5 | Q9NRA2 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 2/20 | 0.44 |
| ▸ | TLR2 | O60603 | 2/20 | 0.43 |
| ▸ | ACE | P12821 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29238560 | 0.93 | MDM4 (0.42) | MDM4TP53MDM2SLC17A5CASP3 | |
| SCHEMBL25081617 | 0.92 | MDM4 (0.42) | MDM4TP53MDM2SLC17A5CASP3 | |
| SCHEMBL25081616 | 0.89 | MDM2 (0.44) | MDM4TP53MDM2SLC17A5CASP3 | |
| SCHEMBL29402061 | 0.88 | MDM4 (0.54) | MDM4TP53MDM2SLC17A5CASP3 | |
| SCHEMBL29398288 | 0.88 | MDM4 (0.54) | MDM4TP53MDM2SLC17A5CASP3 | |
| SCHEMBL29238562 | 0.87 | ACE (0.42) | MDM4TP53MDM2SLC17A5ACE | |
| SCHEMBL30389933 | 0.87 | ACE (0.42) | MDM4TP53MDM2SLC17A5ACE | |
| SCHEMBL31647183 | 0.86 | MDM2 (0.56) | MDM4TP53MDM2SLC17A5CASP3 | |
| SCHEMBL3436129 | 0.80 | MDM4 (0.58) | MDM4TP53MDM2SLC17A5CASP3 | |
| SCHEMBL1001473 | 0.80 | MDM4 (0.58) | MDM4TP53MDM2SLC17A5CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023021173-A1 | PROCESS FOR THE PREPARATION OF PEGYLATED ADRENOMEDULLIN, ITS INTERMEDIATES AND USE THEREOF | BAYER AKTIENGESELLSCHAFT (DE) | 2023-02-23 | — | — | WO | disclosed |